These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33126245)

  • 1. Identification of pan-cancer Ras pathway activation with deep learning.
    Li X; Li S; Wang Y; Zhang S; Wong KC
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33126245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
    Way GP; Sanchez-Vega F; La K; Armenia J; Chatila WK; Luna A; Sander C; Cherniack AD; Mina M; Ciriello G; Schultz N; ; Sanchez Y; Greene CS
    Cell Rep; 2018 Apr; 23(1):172-180.e3. PubMed ID: 29617658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated exploitation of deep learning for cancer patient stratification across multiple types.
    Sun P; Fan S; Li S; Zhao Y; Lu C; Wong KC; Li X
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37934154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations.
    Huang Z; Johnson TS; Han Z; Helm B; Cao S; Zhang C; Salama P; Rizkalla M; Yu CY; Cheng J; Xiang S; Zhan X; Zhang J; Huang K
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):41. PubMed ID: 32241264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating pathway knowledge with deep neural networks to reduce the dimensionality in single-cell RNA-seq data.
    Gundogdu P; Loucera C; Alamo-Alvarez I; Dopazo J; Nepomuceno I
    BioData Min; 2022 Jan; 15(1):1. PubMed ID: 34980200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors.
    Loboda A; Nebozhyn M; Klinghoffer R; Frazier J; Chastain M; Arthur W; Roberts B; Zhang T; Chenard M; Haines B; Andersen J; Nagashima K; Paweletz C; Lynch B; Feldman I; Dai H; Huang P; Watters J
    BMC Med Genomics; 2010 Jun; 3():26. PubMed ID: 20591134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
    Imperial R; Toor OM; Hussain A; Subramanian J; Masood A
    Semin Cancer Biol; 2019 Feb; 54():14-28. PubMed ID: 29175106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using deep learning to associate human genes with age-related diseases.
    Fabris F; Palmer D; Salama KM; de Magalhães JP; Freitas AA
    Bioinformatics; 2020 Apr; 36(7):2202-2208. PubMed ID: 31845988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma.
    Lin YT; Way GP; Barwick BG; Mariano MC; Marcoulis M; Ferguson ID; Driessen C; Boise LH; Greene CS; Wiita AP
    Blood Adv; 2019 Nov; 3(21):3214-3227. PubMed ID: 31698452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PID Controller-Based Stochastic Optimization Acceleration for Deep Neural Networks.
    Wang H; Luo Y; An W; Sun Q; Xu J; Zhang L
    IEEE Trans Neural Netw Learn Syst; 2020 Dec; 31(12):5079-5091. PubMed ID: 32011265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning using bulk RNA-seq data expands cell landscape identification in tumor microenvironment.
    Wang X; Wang H; Liu D; Wang N; He D; Wu Z; Zhu X; Wen X; Li X; Li J; Wang Z
    Oncoimmunology; 2022; 11(1):2043662. PubMed ID: 35251771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS, wanted dead or alive: Advances in targeting RAS mutant cancers.
    Stalnecker CA; Der CJ
    Sci Signal; 2020 Mar; 13(624):. PubMed ID: 32209699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and gene selection of triple-negative breast cancer subtype embedding gene connectivity matrix in deep neural network.
    Liu J; Su R; Zhang J; Wei L
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33415328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing neural networks for medical data sets: A case study on neonatal apnea prediction.
    Shirwaikar RD; Acharya U D; Makkithaya K; M S; Srivastava S; Lewis U LES
    Artif Intell Med; 2019 Jul; 98():59-76. PubMed ID: 31521253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations.
    Jeuken J; van den Broecke C; Gijsen S; Boots-Sprenger S; Wesseling P
    Acta Neuropathol; 2007 Aug; 114(2):121-33. PubMed ID: 17588166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Deep Learning Framework for Predicting Response to Therapy in Cancer.
    Sakellaropoulos T; Vougas K; Narang S; Koinis F; Kotsinas A; Polyzos A; Moss TJ; Piha-Paul S; Zhou H; Kardala E; Damianidou E; Alexopoulos LG; Aifantis I; Townsend PA; Panayiotidis MI; Sfikakis P; Bartek J; Fitzgerald RC; Thanos D; Mills Shaw KR; Petty R; Tsirigos A; Gorgoulis VG
    Cell Rep; 2019 Dec; 29(11):3367-3373.e4. PubMed ID: 31825821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New druggable targets in the Ras pathway?
    Matallanas D; Crespo P
    Curr Opin Mol Ther; 2010 Dec; 12(6):674-83. PubMed ID: 21154159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explainable drug sensitivity prediction through cancer pathway enrichment.
    Tang YC; Gottlieb A
    Sci Rep; 2021 Feb; 11(1):3128. PubMed ID: 33542382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.